PMID: 6409804Aug 1, 1983Paper

Long-term survival of MHC-compatible lymphocytes and two-phase clearance of allogeneic incompatible lymphocytes in the young pig

Immunology
R M Binns, S T Licence

Abstract

Major histocompatibility complex (MHC)-compatible pig lymphocytes survive in vivo for well over a week. In the first day, they show a rapid reduction in numbers followed by reappearance in the blood consistent with equilibration with the lymphoreticular tissue populations, where they are found. By contrast, allogeneic lymphocytes show an early partial clearance and late (40-50 hr) exponential immune clearance.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.